<DOC>
	<DOCNO>NCT00649311</DOCNO>
	<brief_summary>The purpose study compare efficacy eplereonone losartan patient mild moderate hypertension .</brief_summary>
	<brief_title>A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension</brief_title>
	<detailed_description>This Phase 2 study EPLA-0501-072 ( A6141012 ) conduct begin 02 April 2003 prematurely terminate due poor enrollment 12 September 2003 . There statistical analysis efficacy conducted number patient enrol insufficient inferential analysis due poor enrollment . There serious adverse event death report study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>History mild moderate hypertension , newly diagnose hypertension , define seDBP â‰¥90 mmHg &lt; 110 mmHg seSBP &lt; 180 mmHg Withdrawal previous antihypertensive prior singleblind placebo runin period doubleblind treatment period Secondary hypertension ( e.g. , renal , renovascular , adrenocortical disease , pheochromocytoma , Cushing 's syndrome , primary aldosteronism , iatrogenic ) , severe hypertension , malignant hypertension The patient withdraw antihypertensive route include diuretic , alphablockers , betablockers , calcium channel blocker , ACEI , ARB , medication affect blood pressure ; patient stable angina nitrate dosage change within past three month ( i.e. , stable maintenance dose ) eligible study ; sildenafil citrate , theophylline , papaverine must take within 24 hour prior clinic visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>